Ricardo Brage serves as Vice President Spain for Sanofi Pasteur MSD. He discusses how he sought to change the subsidiary in response to pricing…

With the use of generics on the rise in Mexico, thanks to the implementation of Seguro Popular, the country's social security program, PharmaBoardroom…

Why did MSD decide to have Denmark as the headquarters for the Mid Europe 2 region? This Mid Europe 2 region consists of 10 countries, most of…

In Q3 2012, MSD reported worldwide sales of $11.5 billion. What was the contribution that emerging markets had? From an MSD perspective, emerging…

It truly seems that you have pharma in your genes, with a father who successfully developed a migraine drug in addition to your 4 years practicing…

Dr. Novotný, in 2008, you became Managing Director for MSD for the Czech and Slovak Republics. In the very next year after your appointment,…

If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa,…

You have only just arrived from Korea to head the Romanian operations at MSD. Just recently, you told in an interview with Medica Academica that MSD…

Stefan Oschmann, President of the Emerging Markets at Merck and Co. described MSD as the dark horse of the emerging markets. How is MSD performing in…

We read in an article by El Economista last year that you believe “there is no other company with such a diverse range of therapies as MSD and…

MSD China's Michel Vounastos gives his initial impressions of the opportunities and challenges inherent in the Chinese healthcare market, and…

When we were in Australia, we met with the “star scientist” Ian Frazier, who was Australian of the Year in 2009 for his co-discovery of Merck’s…